FBIOP:NASDAQ
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
$17.78
arrow_downward
-1.38%(-0.25) 1D
$17.80
arrow_upward
+0.11% (+0.020)bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for FBIOP...
Open
$17.74
High
$17.96
Low
$17.40
Mkt. cap
69.70M
Avg. vol.
12.51K
Volume
6.31K
52-wk high
$21.43
52-wk low
$6.27
Beta
0.92
Shares outstanding
3.43M
No. of employees
78
Open
$17.74
High
$17.96
Low
$17.40
Mkt. cap
69.70M
Avg. vol.
12.51K
Volume
6.31K
52-wk high
$21.43
52-wk low
$6.27
Beta
0.92
Shares outstanding
3.43M
No. of employees
78
News stories
From web sources and news partners
TipRanks
·
23 minutes ago
Closing Bell Movers: Telecom stocks fall on SpaceX spectrum license
MarketWatch
·
4 hours ago
S&P Global Inc. stock underperforms Thursday when compared to competitors despite daily gains
TradingView
·
3 hours ago
Analyst Sets Stark S&P 500 Target For 2027
Profile
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
About Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
CEOLindsay Rosenwald
Employees78
Founded2006
HeadquartersBay Harbor Islands, Florida, United States
SectorBiotechnology
Websitefortressbiotech.com